A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
Connie Franciosi, 80, was part of a trial that looked at using an mRNA vaccine and an immunotherapy drug to prevent the recurrence of melanoma.
Lynn Winkler
hide caption
toggle caption
Lynn Winkler
A personalized vaccine for melanoma cut the risk of cancer returning after five years
Melanoma, a 5 anni vivo il 92% dei pazienti trattato con il vaccino personalizzato - Focus Tumore news - Ansa.it
Breakthrough melanoma vaccine would slash risk of the deadly cancer returning
Melanoma, a 5 anni vivo il 92% trattato con vaccino personalizzato
Cancer vaccine cuts risk of deadly skin cancer returning by half in
Studie: mRNA-Impfung senkt das Risiko für Hautkrebs-Rückfall
mRNA-Impfung gegen Krebs: Steht der Durchbruch bevor?
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
ASCO26: Cancer vaccines and at-home injectable drugs continue to show promise
Una potencial vacuna contra el cáncer reduce el riesgo de recurrencia y muerte en un 49% en los casos de melanoma
If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.
Dal congresso mondiale di oncologia ASCO in corso a Chicago arriva una importante conferma sull'efficacia del vaccino a mRna…
An estimated 112,000 new melanoma cases and 8,500 deaths are expected this year
Leggi su Sky TG24 l'articolo Melanoma, a 5 anni vivo il 92% trattato con vaccino personalizzato
Patients with deadly skin cancer could soon benefit from a revolutionary vaccine that has been shown to slash the risk of their…
Die Zahl der Hautkrebs-Fälle ist in den vergangenen Jahren stark gestiegen. Eine mRNA-Impfung in Kombination mit einer…
